Back to Market Feed

LAMIVUDINE 300 MG TABLET

lamivudine
$1.2918per EA

Strength

300 mg/1

Manufacturer

Apotex Corp.

NDC

60505325203

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LAMIVUDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA091606

On Market Since

12/2/2011

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

-3.3%

3M

-4.8%

6M

+1.5%

1Y

-21.8%

3Y

-0.0%

5Y

-45.5%

All

-84.9%

Generic Alternatives

1 alternative • Same active ingredient

EPIVIR 300 MG TABLET
Brand
49702020413•ViiV Healthcare Company
$13.2940
+929% more

Related Drugs

Same classification

NEVIRAPINE 200 MG TABLET
Generic
65862002760•Aurobindo Pharma Limited
$0.1314
per EA
NEVIRAPINE 200 MG TABLET
Generic
00378405091•Mylan Pharmaceuticals Inc.
$0.1472
per EA
NEVIRAPINE 200 MG TABLET
Generic
31722050560•Camber Pharmaceuticals Inc.
$0.1472
per EA
NEVIRAPINE 200 MG TABLET
Generic
33342000409•Macleods Pharmaceuticals Limited
$0.1472
per EA
ZIDOVUDINE 50 MG/5 ML SYRUP
Generic
65862004824•Aurobindo Pharma Limited
$0.1499
per ML
NEVIRAPINE 200 MG TABLET
Generic
65162020906•Amneal Pharmaceuticals LLC
$0.1556
per EA
ENTECAVIR 0.5 MG TABLET
Generic
16714071701•NorthStar Rx LLC
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
31722083330•Camber Pharmaceuticals Inc.
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
31722083390•Camber Pharmaceuticals Inc.
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
42494045730•Cameron Pharmaceuticals
$0.2110
per EA